AnaSpec - Model AS-55581 - Human recombinant a-Synuclein (1-140), biotin labeled - 200 µg
From Proteins - Catalog Recombinant
Parkinson's disease is predominantly a movement disorder resulting from degeneration of dopaminergic neurons in the substantia nigra. The cause of the disease is unknown, but substantial evidence suggests that the aggregation of α-synuclein is a critical step in the etiology of Parkinson's disease (PD). α-Synuclein is an abundant brain protein of 140 residues that is present in high concentration at presynaptic terminals and is found in both soluble and membrane-associated fractions of the brain. Several possible functions have been suggested for α-synuclein, and it also appears to be involved in vesicle release and trafficking. In vitro incubation in the presence of a specific amount of salt (i.e. 0.1M NaCl) with agitation shows α-synuclein forming fibrilous structure.
-
Most popular related searches
Specification
Chemistry
- UniProt number : P37840
- Molecular Mass/ Weight : 14.5 kDa
Modification
- Conjugation type : Biotins
- Modification Name : Biotin
- Conjugation : Conjugated
Quantity & Purity
- Concentration : 1 mg/ml
- Purification Method : Purified
Storage & stability
- Form : In solution
- Storage Buffer : 10 mM sodium phosphate buffer (pH=7.4)
- Storage Conditions : Store at -80°C. Avoid repeated freeze-thaw cycles.
Activity
- Application : Aggregation/Fibrillation ELISA Western Blotting
- Biomarker Target : Synuclein
- Specificity : human a-synuclein (1-140)
- Research Area : Neuroscience
- Sub-category Research Area : Parkinson's Disease
- Usage : Research use
Source
- Host : E. coli
- Source / Species : human
Customer reviews
No reviews were found for AnaSpec - Model AS-55581 - Human recombinant a-Synuclein (1-140), biotin labeled - 200 µg. Be the first to review!